feed
S&P 500
NASDAQ
DOW
RUSSELL
VIX
US10Y
DXY
EUR/USD
GBP/USD
GOLD
WTI
BTC
ETH
LLedger

GILD

Gilead Sciences, Inc.
HealthcareDrug Manufacturers - GeneralUSUSD
$134.43
+0.97%Live · FMPMay 29, 2026
AI Brief
Market cap
$166.9B
52w range
104.46 – 157.29
P / E
EPS
Volume
16.64M
Revenue · FY
$29.44B
+2.40% YoY

Stock splits

DB · stock_splits5
DateRatioTypeMultiplier
Jan 28, 20132-for-1Forward2.00×
Jun 25, 20072-for-1Forward2.00×
Sep 07, 20042-for-1Forward2.00×
Mar 08, 20022-for-1Forward2.00×
Feb 22, 20012-for-1Forward2.00×

M&A activity

1DB · FMP /mergers-acquisitions

Whole-company transactions where GILD is acquirer or target.

DateRoleCounterpartyFiling
Jun 23, 1999AcquirerNeXstarSEC →

Beneficial-ownership filings

DB · 13D/G14
FiledFormReporter% ownedShares
Apr 19, 2024Gilead Sciences, Inc.13.90%SEC →
Apr 05, 2024Gilead Sciences, Inc.19.90%SEC →
Feb 20, 2024Gilead Sciences, Inc.9.60%SEC →
Oct 25, 2023Gilead Sciences, Inc.19.90%SEC →
Oct 19, 2023Gilead Sciences, Inc.6.70%SEC →
Feb 13, 202395-14110375.50%SEC →
Feb 06, 2023Gilead Sciences, Inc.7.30%SEC →
Aug 08, 2022Gilead Sciences, Inc.14.80%SEC →
Jul 08, 2022(1)Names of reporting persons. BlackRock, Inc.10.10%SEC →
Feb 17, 2022Gilead Sciences, Inc.4.30%SEC →
Feb 11, 202295-14110378.50%SEC →
Feb 10, 2022Gilead Sciences, Inc.4.30%SEC →
Feb 01, 2022(1) BlackRock, Inc.9.50%SEC →
Sep 10, 2021Gilead Sciences, Inc.5.50%SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.